Our laboratory is staffed by American Board of Medical Genetics and Genomics (ABMGG) certified MDs and PhDs and highly skilled cytogenetic technologists who are certified by the American Society of Clinical Pathologists (ASCP) Board of Registry (BOR) as specialists in cytogenetics and molecular biology. Using both traditional cytogenetic techniques as well as molecular cytogenetics by fluorescence in situ hybridization (FISH) and genome-wide array comparative genomic hybridization (aCGH), the UPMC Cytogenetic Laboratory (UCL) performs state-of-the-art cytogenetic studies on a wide variety of specimens, giving our referring physicians the best opportunity to get the answers they need. The UCL is also a Children’s Oncology Group (COG) approved full-service facility.

The UPMC Clinical Genomics Laboratory (UCGL) is a CAP/CLIA-certified, state-of-the-art genomics facility located at UPMC Magee-Womens Hospital. Our team comprises ABMGG-certified MDs and PhDs, highly skilled PhD genome analysts, ASCP-certified molecular technologists, and ABGC-certified genetic counselors. We offer comprehensive testing services, including diagnosis through whole exome sequencing and disease-specific panels, hereditary cancer predisposition screening, carrier screening, and pharmacogenetic analysis, utilizing cutting-edge molecular technologies such as next-generation sequencing (NGS). Beyond testing, we collaborate closely with physicians and researchers to evaluate emerging technologies, develop innovative molecular tests to improve patient care, and translate groundbreaking discoveries into clinical practice.